Indian pharma to be in global top 5 by 2020: study

Image
Press Trust of India Rajkot, Gujarat
Last Updated : Jan 21 2013 | 12:12 AM IST

India will emerge as one of the Top 5 global markets for pharmaceutical products by 2020, driven by huge domestic demand and increased consumer spending on drugs, according to a study by city-based Ikon Marketing Consultants.

Describing the ongoing decade as a healthy one for the pharma industry, Ikon Marketing Consultants (IMC) Founder and Principal Consultant Azaz Motiwala said, "The global pharma market is expected to grow at 7% to 8% over the next five years, reaching an anticipated $1.7 trillion in 2020."

He noted that the Indian consumer currently spends nearly 1% of his total income on drugs and pharmaceuticals, which will not change significantly in the current decade.

"However, with the rise in the per capita income, the spending is going to be triple (approximately $33) by 2020," Motiwala said.

By 2020, nearly 650 million people will have health insurance cover, while private insurance coverage will grow by nearly 15% annually till 2020, he said.

By 2020, the Indian healthcare industry is estimated to be worth $275.6 billion, he said.

According to the study, in the current decade, the spread of diabetes will drive the growth of new therapies in India's pharmaceutical market and by 2020, incidence of the disease will have risen six times.

Diabetes presently affects around 50 million Indians, killing about 4 million annually, as per official statistics.

"Treatment for chronic diseases like asthma, cancer, diabetes, heart ailments, osteoporosis and kidney ailments will likely to constitute more than half of India's pharma market by the end of the decade," Motiwala said.

Emerging areas such as bio pharmaceuticals, bio generics, bio similar and pharma packaging are also going to contribute significantly to the industry's growth, the study says.

According to the study, metros and Tier-1 markets, which have been growing at 14-15% in the last five years, will drive growth in the industry.

They account for 60% of the Indian pharmaceutical market today and look set to continue growing to a market size of $33 billion by the end of the decade, Motiwala said.

Rural areas, on the other hand, will constitute 25% of the total market, by 2020, up from 20% at present.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Sep 13 2011 | 12:23 PM IST

Next Story